Page 22 of 44.
A comprehensive clinical and harm-reduction guide to Diphenhydramine (Benadryl) in India, exploring its anticholinergic mechanism, the 'Hatman' deliriant phenomenon, Jan Aushadhi pricing, and the risk of early-onset dementia as of 2026.
A comprehensive clinical and harm-reduction guide to Chlorpheniramine (CPM) in India, exploring its H1-receptor mechanism, its role in cough syrup 'cocktails', Jan Aushadhi pricing, and the risk of paradoxical excitation as of 2026.
A comprehensive clinical and harm-reduction guide to Hydroxyzine (Atarax) in India, exploring its H1 and dopamine mechanism, its role in opioid withdrawal management, Jan Aushadhi pricing, and the risk of QT prolongation as of 2026.
A comprehensive clinical and harm-reduction guide to Trihexyphenidyl (Pacitane) in India, exploring its anticholinergic mechanism, its misuse as a deliriant (the 'Five-Star' high), Jan Aushadhi pricing, and the risk of cognitive collapse as of 2026.
A comprehensive clinical and harm-reduction guide to Atropine in India, exploring its muscarinic antagonism, its life-saving role in pesticide poisoning, Jan Aushadhi pricing, and the risk of anticholinergic toxicity as of 2026.
An exhaustive clinical guide to Morphine in India, covering its history from the British era to its current status as an Essential Narcotic Drug, pricing, pharmacology, and harm-reduction strategies as of 2026.
A comprehensive clinical and harm-reduction guide to Scopolamine (Hyoscine) in India, exploring its amnesic properties, its reputation as the 'Devil's Breath', Jan Aushadhi pricing, and the 2026 crackdown on its illicit use in traveler scams.
A comprehensive clinical and harm-reduction guide to Amitriptyline (Tryptomer) in India, exploring its role in chronic pain, the narrow therapeutic index, Jan Aushadhi pricing, and the risk of fatal cardiac arrhythmias in 2026.
A comprehensive clinical and harm-reduction guide to Quetiapine (Qutipin) in India, exploring its atypical antipsychotic mechanism, its misuse as a 'sleeper' or 'downer', Jan Aushadhi pricing, and the 2026 metabolic crisis.
A comprehensive clinical and harm-reduction guide to Bupropion (Bupron) in India, exploring its NDRI mechanism, its role in smoking cessation and Adult ADHD, Jan Aushadhi pricing, and the dose-dependent seizure risk as of 2026.
A comprehensive clinical and harm-reduction guide to Nandrolone in India, exploring its anabolic benefits in anemia, its widespread misuse in gyms, Jan Aushadhi pricing, and the risk of 'Deca Dick' and heart failure as of 2026.
A comprehensive clinical and harm-reduction guide to Testosterone in India, exploring its role in hormone replacement, its widespread misuse in the TRT and bodybuilding culture, Jan Aushadhi pricing, and the risk of permanent infertility as of 2026.